Tracon Pharmaceuticals Inc Reports Results For The Quarter Ended In March: Earnings Summary

TRACON Pharmaceuticals

10/05/2023 22:47

* TRACON Pharmaceuticals Inc  TCON.OQ  reported a quarterly
adjusted loss of 36 cents​​ per share for the quarter ended in
March. The mean expectation of three analysts for the quarter
was for a loss of 26 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * TRACON Pharmaceuticals Inc's reported EPS for the quarter
was a
loss of 36 cents​.
    * The mean earnings estimate of analysts had risen by
about 5.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * TRACON Pharmaceuticals Inc shares had fallen by 62.3% this
quarter and lost 52.2% so far this year.
    * The company reported a quarterly loss of $8.5 million.
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $8.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
10 at 09:47 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.26          -0.36          Missed
 Dec. 31 2022      -0.27          -0.31          Missed
 Sep. 30 2022      -0.28          -0.30          Missed
 Jun. 30 2022      -0.37          -0.31          Beat